labetalol has been researched along with esmolol in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (6.67) | 18.7374 |
| 1990's | 13 (43.33) | 18.2507 |
| 2000's | 7 (23.33) | 29.6817 |
| 2010's | 6 (20.00) | 24.3611 |
| 2020's | 2 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Chang, Q; Chen, Z; Hu, G; Hu, L; Li, Q; Long, J | 1 |
| Dimich, I; Sampson, I; Singh, PP; Sonnenklar, N | 1 |
| Brown, M; Hauger, R; Mirow, A; Partridge, BL; Weinger, MB | 1 |
| Hauger, R; Mirow, A; Partridge, BL; Weinger, MB | 1 |
| Black, S; Cucchiara, RF; Losasso, TJ; Muzzi, DA | 1 |
| Lam, AM | 1 |
| Luntley, JB; O'Connor, B | 1 |
| Alfillé, PH; Castelli, I; Drop, LJ; Kaufmann, MA; Schouten, R; Steiner, LA; Welch, CA | 1 |
| Parr, MJ | 2 |
| Carpenter, RL; Guertin, SR; Kalyanaraman, M; McGlew, MJ | 1 |
| Ayuso, A; Luis, M; Sala, X; Sánchez, J; Traserra, J | 1 |
| Castelli, I; Drop, L; Kaufmann, M | 1 |
| Croce, MA; Davis, KA; Fabian, TC; Gavant, ML; Haan, CK; Melton, SM; Pate, JW; Patton, JH; Weiman, DS | 1 |
| Marik, PE; Varon, J | 2 |
| Goldberg, ME; Goldman, S; Levette, A; McNulty, S | 1 |
| Gray, RJ | 1 |
| Komotar, RJ; Mayer, SA; Mocco, J; Rose, JC | 1 |
| Brock-Utne, JG; Chandel, A; Lemmens, HJ; Solvason, HB; van der Starre, PJ | 1 |
| Marik, PE; Rivera, R | 1 |
| Freundlich, RE; Kheterpal, S; Mashour, GA; Matlen, L; Merte, J; Nallamothu, BK; Shanks, A; Sharifpour, M; Tremper, KK; Vlisides, PE; Weightman, A | 1 |
| Birkenhäger, TK; Boere, E; Groenland, TH; van den Broek, WW | 1 |
| Leong, CR; Mahmoud, AA; Myers, KL | 1 |
9 review(s) available for labetalol and esmolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The choice of controlled hypotension during repair of intracranial aneurysms: techniques and complications.
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Constriction; Humans; Hypotension, Controlled; Intracranial Aneurysm; Intraoperative Care; Isoflurane; Labetalol; Nitroprusside; Propanolamines; Trimethaphan | 1990 |
Cardiopulmonary compromise after use of topical and submucosal alpha-agonists: possible added complication by the use of beta-blocker therapy.
Topics: Administration, Intranasal; Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Child; Epinephrine; Female; Heart Arrest; Humans; Hypertension; Intraoperative Complications; Intubation, Intratracheal; Labetalol; Male; Phenylephrine; Propanolamines; Pulmonary Edema | 1997 |
The diagnosis and management of hypertensive crises.
Topics: Antihypertensive Agents; Aortic Aneurysm; Aortic Dissection; Clonidine; Diazoxide; Enalaprilat; Female; Fenoldopam; Humans; Hypertension; Labetalol; Nicardipine; Nifedipine; Nitroprusside; Phentolamine; Pre-Eclampsia; Pregnancy; Propanolamines; Trimethaphan | 2000 |
Postcardiac surgical hypertension.
Topics: Cardiac Surgical Procedures; Heart Rate; Humans; Hypertension; Labetalol; Nitroprusside; Norepinephrine; Postoperative Complications; Propanolamines; Vascular Resistance | 1988 |
Blood pressure management in patients with intracerebral and subarachnoid hemorrhage.
Topics: Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Blood Volume; Brain; Brain Ischemia; Evidence-Based Medicine; Homeostasis; Humans; Intracranial Aneurysm; Intracranial Hemorrhage, Hypertensive; Intracranial Pressure; Labetalol; Nicardipine; Oxygen Consumption; Propanolamines; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2006 |
Perioperative hypertension management.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Enalaprilat; Fenoldopam; Hemodynamics; Humans; Hydralazine; Hypertension; Incidence; Labetalol; Nicardipine; Nitroglycerin; Nitroprusside; Perioperative Care; Postoperative Complications; Propanolamines; Pyridines; Surgical Procedures, Operative; Vascular Resistance; Vasodilator Agents | 2008 |
Hypertensive emergencies: an update.
Topics: Acute Disease; Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Critical Care; Critical Illness; Emergency Medical Services; Humans; Hypertension; Labetalol; Nicardipine; Prevalence; Propanolamines; United States | 2011 |
Beta-blocking agents during electroconvulsive therapy: a review.
Topics: Adrenergic beta-Antagonists; Cardiovascular Diseases; Electroconvulsive Therapy; Humans; Labetalol; Morpholines; Propanolamines; Randomized Controlled Trials as Topic; Urea | 2014 |
6 trial(s) available for labetalol and esmolol
| Article | Year |
|---|---|
A comparison of esmolol and labetalol for the treatment of perioperative hypertension in geriatric ambulatory surgical patients.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Ambulatory Surgical Procedures; Analysis of Variance; Blood Pressure; Cataract Extraction; Female; Heart Rate; Humans; Hypertension; Injections, Intravenous; Intraoperative Complications; Labetalol; Male; Multivariate Analysis; Posture; Propanolamines; Supine Position; Systole; Time Factors | 1992 |
Prevention of the cardiovascular and neuroendocrine response to electroconvulsive therapy: II. Effects of pretreatment regimens on catecholamines, ACTH, vasopressin, and cortisol.
Topics: Adrenocorticotropic Hormone; Adult; Aged; Arginine Vasopressin; Catecholamines; Electroconvulsive Therapy; Hemodynamics; Humans; Hydrocortisone; Labetalol; Middle Aged; Propanolamines | 1991 |
Prevention of the cardiovascular and neuroendocrine response to electroconvulsive therapy: I. Effectiveness of pretreatment regimens on hemodynamics.
Topics: Adult; Aged; Blood Pressure; Double-Blind Method; Electrocardiography; Electroconvulsive Therapy; Fentanyl; Heart Rate; Hemodynamics; Humans; Labetalol; Lidocaine; Middle Aged; Propanolamines | 1991 |
Comparative effects of esmolol and labetalol to attenuate hyperdynamic states after electroconvulsive therapy.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Blood Pressure; Electrocardiography; Electroconvulsive Therapy; Heart Rate; Humans; Labetalol; Middle Aged; Premedication; Propanolamines; Prospective Studies | 1995 |
Effects of anesthetic technique on the hemodynamic response to microlaryngeal surgery.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Anesthesia, Intravenous; Blood Gas Analysis; Endoscopy; Female; Hemodynamics; Humans; Labetalol; Laryngeal Neoplasms; Laryngoscopy; Male; Microsurgery; Middle Aged; Monitoring, Intraoperative; Propanolamines | 1997 |
The effects of esmolol and labetalol on cerebral blood flow velocity during electroconvulsive therapy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Blood Flow Velocity; Blood Pressure; Cerebrovascular Circulation; Electroconvulsive Therapy; Female; Heart Rate; Humans; Hypertension; Labetalol; Male; Middle Aged; Middle Cerebral Artery; Propanolamines; Prospective Studies; Time Factors; Ultrasonography, Doppler, Transcranial | 2008 |
15 other study(ies) available for labetalol and esmolol
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Drug repurposing and rediscovery: Design, synthesis and preliminary biological evaluation of 1-arylamino-3-aryloxypropan-2-ols as anti-melanoma agents.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; Drug Repositioning; Drug Screening Assays, Antitumor; Humans; Melanoma; Molecular Docking Simulation; Molecular Structure; Propanols; Skin Neoplasms; Structure-Activity Relationship; Tumor Cells, Cultured | 2020 |
Labetalol and esmolol in the control of hypertension after intracranial surgery.
Topics: Adrenergic beta-Antagonists; Anesthesia, General; Brain; Heart Rate; Humans; Hypertension; Labetalol; Postoperative Complications; Propanolamines | 1990 |
Acute dissection of the thoracic aorta. Esmolol is safer than and as effective as labetalol.
Topics: Acute Disease; Adrenergic beta-Antagonists; Aortic Aneurysm, Thoracic; Aortic Dissection; Humans; Labetalol; Propanolamines | 1995 |
Drug smuggler's delirium.
Topics: Adrenergic beta-Antagonists; Cocaine; Drug and Narcotic Control; Humans; Labetalol; Poisoning; Propanolamines | 1993 |
Cocaine dosage in rhinosurgery.
Topics: Adrenergic beta-Antagonists; Cardiovascular Diseases; Cocaine; Humans; Labetalol; Propanolamines | 1993 |
Comparative doses and cost: esmolol versus labetalol during electroconvulsive therapy.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Blood Pressure; Cost Savings; Drug Costs; Electroconvulsive Therapy; Humans; Hypertension; Labetalol; Propanolamines; Tachycardia; Therapeutic Equivalency | 1998 |
Prospective study of blunt aortic injury: helical CT is diagnostic and antihypertensive therapy reduces rupture.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aneurysm, False; Antihypertensive Agents; Aorta; Aortic Rupture; Aortography; Drug Therapy, Combination; Female; Humans; Labetalol; Male; Middle Aged; Nitroprusside; Propanolamines; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Wounds, Nonpenetrating | 1998 |
Intravenous labetalol for induced hypotension in an adult patient undergoing coarctation repair.
Topics: Adult; Aortic Coarctation; Halothane; Humans; Hypotension, Controlled; Labetalol; Male; Nitroprusside; Propanolamines | 1988 |
Perioperative metoprolol and risk of stroke after noncardiac surgery.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Analysis of Variance; Atenolol; Cohort Studies; Data Interpretation, Statistical; Female; Humans; Incidence; Labetalol; Logistic Models; Male; Metoprolol; Middle Aged; Monitoring, Intraoperative; Odds Ratio; Postoperative Complications; Propanolamines; Retrospective Studies; Risk Factors; Stroke; Treatment Outcome; Young Adult | 2013 |
Hemodynamic Safety of Continuous Infusion Labetalol Versus Esmolol Combination Therapies for Type B Aortic Dissections.
Topics: Aortic Dissection; Blood Pressure; Hemodynamics; Humans; Labetalol; Propanolamines; Retrospective Studies | 2021 |